Sanofi stock: results on October 30, 2026 ahead of the Xetra open
Published on 10/21/2026 at 08:10 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSUpcoming company events
- Sanofi will present its third-quarter 2026 results on October 30, 2026.
- The Jefferies Global Healthcare Conference is scheduled for November 17, 2026.
- Sanofi stock trades pre-market at EUR 73.92 at 8:10 a.m. CEST at Lang & Schwarz on October 21, 2026.
Sanofi’s next quarterly results are scheduled for October 30, 2026, according to the company’s investor-relations calendar. Sanofi stock trades pre-market at EUR 73.92 at 8:10 a.m. CEST at Lang & Schwarz on October 21, 2026.
Results date ahead
Sanofi said management will review third-quarter 2026 results during a live audio webcast on October 30, 2026, from 1:30 p.m. to 2:30 p.m. CET. The presentation will be followed by a question-and-answer session with the financial community, according to the company’s investor-relations page.
Pre-market trading
Lang & Schwarz lists a bid of EUR 73.87 and an ask of EUR 73.96. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sanofi stock.
The group and its market
Sanofi develops and sells prescription medicines and human vaccines, generating revenue across pharmaceutical and vaccine markets, according to MarketScreener’s company profile. The company is also scheduled to appear at the Jefferies Global Healthcare Conference in London on November 17, 2026. Market context: Market report CAC 40.
